Last update 23 Jan 2025

RA190

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
ADRM1
Mechanism
ADRM1 inhibitors(ADRM1 26S proteasome ubiquitin receptor inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Hepatocellular CarcinomaMultiple MyelomaNeoplasms
Inactive Indication-
Originator Organization
The Johns Hopkins UniversityThe Johns Hopkins University
Active Organization
Chang Gung Memorial HospitalDana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.Xcess Biosciences, Inc.Xcess Biosciences, Inc.
+ [2]
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC28H22Cl4N2O2
InChIKeyIYJSFPQYTFFTKN-SANMLTNESA-N
CAS Registry1617572-02-7

Related

100 Clinical Results associated with RA190
Login to view more data
100 Translational Medicine associated with RA190
Login to view more data
100 Patents (Medical) associated with RA190
Login to view more data
100 Deals associated with RA190
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPreclinical
CN
Chang Gung Memorial Hospital
15 Jul 2016
Multiple MyelomaPreclinical
US
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
06 Dec 2014
Multiple MyelomaPreclinical
US
Xcess Biosciences, Inc.Xcess Biosciences, Inc.
06 Dec 2014
Multiple MyelomaPreclinical
US
Selleck Chemicals LLCSelleck Chemicals LLC
06 Dec 2014
NeoplasmsPreclinical
US
The Johns Hopkins UniversityThe Johns Hopkins University
01 Dec 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free